Literature DB >> 6847380

The influence of haemoperfusion on white cells, immunoglobulin concentrations and the complement system in the treatment of intoxications.

J H Rommes, B Sangster, F H Gmelig Meyling, M R Daha, A N van Heijst.   

Abstract

The influence of haemoperfusion on some immunological parameters was investigated in a pilot study involving two groups of three patients each. In columns containing cellulose-coated activated charcoal or polystyrene resin a temporary reduction of the total white cell number, particularly involving the segmented and band neutrophils, was demonstrated. Cellulose-coated activated charcoal and, to a lesser extent, polystyrene resin induced activation of the complement system using C3d as a parameter. An appreciable decrease of immunoglobulin or complement levels could not be demonstrated in either column.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847380     DOI: 10.1007/bf00354774

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  [The pros and cons of haemoperfusion (author's transl)].

Authors:  H Hennemann; I E Richter; D Brunswig; A Röckel; J Kult; W Gattenlöhner; A Heidland
Journal:  Klin Wochenschr       Date:  1977-06-01

2.  Acute cardiopulmonary decompensation and complement activation during hemodialysis.

Authors:  J W Agar; J D Hull; M Kaplan; P G Pletka
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

3.  [Disorders of blood coagulatiion during haemoperfusion (author's transl)].

Authors:  H Niessner; M Pichler
Journal:  Wien Klin Wochenschr       Date:  1977-05-13       Impact factor: 1.704

4.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.

Authors:  D E Chenoweth; S W Cooper; T E Hugli; R W Stewart; E H Blackstone; J W Kirklin
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

5.  Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA.

Authors:  R H Kauffmann; W A Herrmann; C J Meÿer; M R Daha; L A Van Es
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

6.  The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications: a comparative study of three types of columns (Haemocol, Amberlite XAD-4, Gambro Adsorba 300 C).

Authors:  B Sangster; A N van Heijst; J J Sixma
Journal:  Arch Toxicol       Date:  1981-07       Impact factor: 5.153

7.  The safety assessment in the dog of a charcoal haemoperfusion column.

Authors:  J C Kolthammer; P A Watson; S Lang; J Fennimore
Journal:  Clin Sci Mol Med       Date:  1976-12

8.  Hemoperfusion with Amberlite resin in the treatment of self-poisoning.

Authors:  A Heath; K Delin; E Edén; E Mårtensson; D Selander; I Wickström; J Ahlmén
Journal:  Acta Med Scand       Date:  1980

9.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  1 in total

1.  Biocompatibility of haemoperfusion.

Authors:  J H Rommes; B Sangster; L Berrens; C Borst; A N van Heijst
Journal:  Arch Toxicol       Date:  1986-02       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.